drug · oligonucleotide
patient view →Hypertriglyceridemia
pre_registrationupdated 2mo agoby LP Pharmaceutical (Xiamen) Co Ltd🔗 ChEMBL
community read0 votes
Oligonucleotide drug with a maximum clinical stage of Approval (across all indications), with 3 approved and 3 investigational indications.
targets
Apolipoprotein C-III mRNA 3'UTR
all catalysts(0)
nothing on the calendar yet
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that